通威股份(600438.SH):與隆基股份建立長期穩定的多晶硅料供需關係等事項達成合作意向
格隆匯 9 月 25日丨通威股份(600438.SH)公佈,為積極推進戰略合作事項,在上述戰略合作思路指導下,考慮當前市場的變化和雙方需要,雙方經協商一致,對合作的相關事項進行了調整,並於2020年9月25日籤訂了《合作協議》、《四川永祥新能源有限公司增資擴股協議》、《雲南通威高純晶硅有限公司投資協議》,就隆基股份參股投資公司的控股子公司四川永祥新能源有限公司(“永祥新能源”)和雲南通威高純晶硅有限公司(“雲南通威”),並與隆基股份建立長期穩定的多晶硅料供需關係等事項達成合作意向。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.